Impaired incretin effect is an early sign of glucose dysmetabolism in nondiabetic patients with psoriasis-Reference-Cited by-同舟云学术

Impaired incretin effect is an early sign of glucose dysmetabolism in nondiabetic patients with psoriasis

Published:2015-07-14 Issue:6 Volume:278 Page:660-670
ISSN:0954-6820
Container-title:Journal of Internal Medicine
language:en
Short-container-title:J Intern Med

Author:

Gyldenløve M.¹,Vilsbøll T.²,Zachariae C.¹,Holst J. J.³,Knop F. K.²³,Skov L.¹

Affiliation:

1. Department of Dermato-Allergology; Gentofte Hospital; University of Copenhagen; Hellerup Denmark

2. Center for Diabetes Research; Gentofte Hospital; University of Copenhagen; Hellerup Denmark

3. NNF Centre for Basic Metabolic Research; Department of Biomedicine; Faculty of Health and Medical Sciences; University of Copenhagen; Copenhagen Denmark

Funder

Abbvie

Alfred Helsteds og Eli Møllers Legat

C. C. Klestrup og hustru Henriette Klestrups Mindelegat

Carl og Ellen Hertz legat til dansk laege- og naturvidenskab

Fonden af 1870

Psoriasis Forskningsfonden

Aase og Ejnar Danielsens Fond

Publisher

Wiley

Subject

Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/joim.12388/fullpdf

Reference39 articles.

1. Psoriasis and the risk of diabetes mellitus: a systematic review and meta-analysis;Armstrong;JAMA Dermatol,2013

2. Psoriasis, psoriatic arthritis and type 2 diabetes mellitus: a systematic review and meta-analysis;Coto-Segura;Br J Dermatol,2013

3. Psoriasis and new-onset diabetes: a Danish nationwide cohort study;Khalid;Diabetes Care,2013

4. The incretin system and its role in type 2 diabetes mellitus;Holst;Mol Cell Endocrinol,2009

5. Reduced incretin effect in type 2 (non-insulin-dependent) diabetes;Nauck;Diabetologia,1986

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oral glucose has little or no effect on appetite and satiety sensations despite a significant gastrointestinal response;European Journal of Endocrinology;2023-11-30

2. Exploring the molecular mechanism underlying the psoriasis and T2D by using microarray data analysis;Scientific Reports;2023-11-07

3. Deciphering the Molecular Mechanisms Underlying the Psoriasis and T2D: A Systems Biology Approach Using Microarray Data Analysis;2023-06-13

4. Efficacy of ixekizumab in patients with moderate-to-severe plaque psoriasis and prediabetes or type 2 diabetes;Frontiers in Medicine;2023-01-27

5. Emerging roles of Glucagon like peptide-1 in the management of autoimmune diseases and diabetes-associated comorbidities;Pharmacology & Therapeutics;2022-11